Skip to content

RCT on 3 Types of Hysterectomy

A Multinational Randomized Controlled Trial Including Two Identical Sub Studies Comparing Vaginal Versus vNOTES (Vaginal Natural Orifice Transluminal Surgery) Hysterectomy or Laparoscopic Versus vNOTES Hysterectomy.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05971875
Acronym
VANOLAH
Enrollment
1000
Registered
2023-08-02
Start date
2024-01-01
Completion date
2026-01-01
Last updated
2024-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minimally Invasive Surgery

Brief summary

A randomized controlled trial comparing the vaginal, vNOTES ( vaginal natural orifice transluminal surgery) or laparoscopic approach for hysterectomy in women with benign gynaecological disease

Detailed description

Multi-center pragmatic non-blinded RCT including 1000 women 18-75 years in need of hysterectomy for benign disease; comparing VH vs vNOTES or LH vs vNOTES.

Interventions

PROCEDUREvNOTES vs Vaginal Hysterectomy

Comparison of vNOTES vs VH

PROCEDUREvNOTES vs Laparoscopic Hysterectomy

Comparison of vNOTES vs LH

Sponsors

Dr Jan Baekelandt, MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

• Women aged 18 to 75 years regardless of parity with benign indication for hysterectomy

Exclusion criteria

* Women with a stage II+ prolapse in need of a hysterectomy as part of vaginal prolapse repair * hysterectomy due to suspected endometriosis * subtotal hysterectomy * history of rectal surgery * suspected malignancy * suspected obliteration of the pouch of Douglas following severe PID or other causes * active lower genital tract infection * pregnancy * failure to provide written informed consent prior to surgery * requirement of in-patient care due to other co-morbidities

Design outcomes

Primary

MeasureTime frameDescription
proportion of women leaving the hospital within 12 hours after surgery complications.12 hoursDay sugery

Secondary

MeasureTime frameDescription
conversion rates12 hoursconversion to different surgival technique
duration of the surgical procedure12 hoursfrom placement of Foley to last stich
Intraoperative complications.12 hoursComplication
Hospitalization time6 weeksTime admitted
re-admission requiring hospitalization6 weeksReadminssion
Patient Reported Outcome Measures.3 months postopShort Female Sexual Function Index.
postoperative complications,6 weeksClavien Dindo

Countries

Croatia, Sweden

Contacts

Primary ContactJan Baekelandt, Prof
jan.baekelandt@imelda.be0032499471371
Backup ContactJan Baekelandt
jan.baekelandt@imelda.be0032499471371

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026